University of Miami Department of Otolaryngology
Miami, Florida, 33175, United States
NCT Number: NCT03143296
The purpose of this study is to investigate speech understanding in simulated reverberant environments with MED-EL cochlear implant recipients.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Miami, Florida, 33175, United States
The study will determine if electrode length and coding strategy effect performance. The investigator will also study performance over time with new recipients.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Reverberant environments simulate real-life situations mimicking a living room, classroom and auditorium. Each simulation lasts up to 2 hours.
Time frame: Up to six months
Speech performance recorded as percent correct compared to different electrode lengths.
Time frame: Two hours
Speech scores, in percent correct, recorded from simulated reverberant speech tests will be compared between fine structure and envelope coding strategies.
University of Miami
Other
The Effects of Reverberation on Speech Understanding in MED-EL Cochlear Implant Recipients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06424262
Ear Diseases, Hearing Disorders
Sydney, New South Wales, Australia
View Trial DetailsNCT03686046
Ear Diseases, Hearing Disorders
San Diego, California, United States
View Trial DetailsNCT07667140
Ear Diseases, Hearing Disorders
Oldenburg, Germany
View Trial DetailsNCT06176625
Behavior, Behavioral Symptoms
Baltimore, Maryland, United States
View Trial Details